about
An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list.Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial.The association between patients' beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire survey.Inappropriate Prescription and Renal Function Among Older Patients with Cognitive Impairment.Drug-related hospital admissions among old people with dementia.Doctors' and nurses' perceptions of a ward-based pharmacist in rural northern SwedenSocioeconomic Inequalities in the Prescription of Oral Anticoagulants in Stroke Patients With Atrial Fibrillation.Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke.Few sex differences in the use of drugs for secondary prevention after stroke: a nationwide observational study.Effects of Pharmacists' Interventions on Inappropriate Drug Use and Drug-Related Readmissions in People with Dementia-A Secondary Analysis of a Randomized Controlled Trial.Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluationClinically relevant drug-drug interactions among elderly people with dementiaInequalities in medication adherence to statin treatment after stroke: A nationwide observational studyInvestigating the effect of clinical pharmacist intervention in transitions of care on drug-related hospital readmissions among the elderly: study protocol for a randomised controlled trial
P50
Q33653858-9C1C0CD7-2BD9-4601-AF3C-538E071C6AF3Q33841837-91E7CDD9-CA9B-4B78-AD80-5C49D6B50B04Q37208459-EC545BF4-919E-4B74-95CC-DFAE80BA4915Q37438223-65AEBE62-6D56-4A89-AD53-6C6B7F0AF594Q39632952-3B384DBF-1821-429B-880C-FAD50F6E1BEDQ41223071-B54C6F6E-E86E-4DC9-8C65-7A3926916114Q41663983-ED2D01BA-804C-4C48-84E2-390C08D99AD6Q43194111-2CDC5548-66E8-46A7-A3D0-71500EC06955Q45348319-08B2728D-5E3D-47DA-AD9D-6E493960BE3FQ48235862-A3DAF743-F9AF-48C6-B89C-CEA047F2106BQ88736357-13905381-FF70-45C2-A3A0-7433B5E444E9Q89396566-AF077EF0-2705-4B88-973D-72F3622CFC08Q90106686-26C84E37-8810-48CB-8E1C-40E8737B4F96Q94451716-33294950-ACD9-4D21-B5DD-DC598000960D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Sjölander
@ast
Maria Sjölander
@en
Maria Sjölander
@es
Maria Sjölander
@nl
type
label
Maria Sjölander
@ast
Maria Sjölander
@en
Maria Sjölander
@es
Maria Sjölander
@nl
prefLabel
Maria Sjölander
@ast
Maria Sjölander
@en
Maria Sjölander
@es
Maria Sjölander
@nl
P106
P31
P496
0000-0002-8364-6290